Berliner Institut für Gesundheitsforschung - Charité und Max-Delbrück-Centrum

What Cells does the novel Coronavirus attack?

Researchers*at the BIH, the Charité and the Thorax Clinic of the University Hospital Heidelberg have investigated which cells in the lung can be attacked by the coronavirus SARS-CoV-2.

To the press release

Corona app: BIH and Charité join forces against the virus

Alexander H. Thieme, Digital Clinician Scientist at BIH, programmed the CovApp so that people can determine their own risk of infection with the coronavirus SARS-CoV-2.

To the press release (in German)

Coordinated Research on Measures to Fight COVID-19

BIH QUEST, the German Network for Evidence-based Medicine (DNEbM) and the German Academy of Ethics in Medicine (AEM) are calling for research into the effectiveness of measures against Sars-CoV-2.

To the press release

Call: BIH Digital Health
Accelerator 2020

The application period for the program BIH Digital Health Accelerator has been extended to May 5th, 2020. For further information, please refer to the website of this call for applications.

To the call

Call: BIH Charité (Junior) Clinician Scientist Programm

We are looking forward to receiving applications for the BIH Charité (Junior) Clinician Scientist Program and the (Junior) Digital Clinician Scientist Program. Deadline is May 12, 2020.

To the calls

Our mission: Translation!

The mission of the BIH is medical translation: The BIH aims to translate findings from biomedical research into new approaches for personalised prediction, prevention and therapy and, conversely, to develop new research approaches from clinical observations. The goal is always the medical benefit for patients*.

More about the mission of the BIH

A new Chapter for the Berlin Institute of Health

Anja Karliczek and Michael Müller signed an administrative agreement on the integration of the BIH into Charité.

What does it mean to be a scientist?

In ten video portraits, BIH female scientists present their contribution to translational research, from basic research to clinical application: diverse and inspiring and!